The Jaklenec Lab

Engineering delivery systems for global health

The Jaklenec Research Lab at the MIT Koch Institute for Integrative Cancer Research works at the interface of engineering and immunology with a focus on global health. The lab develops innovative and translatable technologies to help large populations globally, especially in developing countries.

Microparticles to control the pulsatile release of biologics
Microparticles to control the pulsatile release of biologics
Medical information storage under the skin
Medical information storage under the skin
Microparticles to help fight malnutrition
Microparticles to help fight malnutrition
Probiotic and antibiotics combined to eradicate drug-resistant bacteria
Probiotic and antibiotics combined to eradicate drug-resistant bacteria
A predictive framework for microparticle-based drug injectability
A predictive framework for microparticle-based drug injectability
Journal covers

Recent News

Dr. Jaklenec Beilstein Talks Presentation
September 22, 2025
Next-Generation Drug and Vaccine Delivery for Global Health…

Collaboration with Harvard Published in Cell
September 15, 2025
Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines…

Khanh Tran Wins Koch Institute Marlena Felter Bradford Research Travel Award
August 26, 2025
Congratulations Dr. Tran! These awards are made possible by donors to the Koch Institute and funds they have created to support our trainees and community.

More news >>